TAC Competition Lawsuit

Treatment Access Campaign Competition Lawsuit Against GlaxoSmithKline and Boehringer-Ingelheim

Competition Commission Documents

SETTLEMENT AGREEMENT.
December 10, 2003. Competition Commission concludes an agreement with pharmaceutical firms.
October 16, 2003. Competition Commission finds pharmaceutical firms in contravention of the Competition Act.

Documents Submitted by CPTech

Affidavit of James Love.
Statement of Information by Consumer Project on Technology Concerning an Alleged Prohibited Practice in Terms of Section 49B(2)(a) of the Competition Act 89 of 1998.

TAC Documents

December 14, 2004. GlaxoSmithKline grants license to Cipla in accordance with Competition Commission settlement.
December 10, 2003. A Victory for People living with HIV/AIDS and for public health!
October 16, 2003. Competition Commission Finds GSK and BI in Contravention of the Competition Act.
November 20, 2002. Treatment Access Campaign letter to GlaxoSmithKline on monopoly pricing, asking for voluntary licenses for antriretrovirals at a 5% royalty. Excessive Prices of Medicines Are Responsible for the Deaths of Millions in South Africa! Stop Profiteering Now!
September 19, 2002. Statement by TAC on Excessive Pricing Complaint to Competition Commission.
Legal Documents Submitted by TAC.

NGO Statements

December 10, 2003. AIDS Healthcare Foundation. AIDS Healthcare Foundation Says South African Competition Commission Settlement On GSK’s AIDS Drug Pricing, "Too Little, Too Late".
December 10, 2003. Brook Baker for Health GAP. Threat of Compulsory Licenses at the South African Competition Commission Results in Generic Licenses for AIDS Medicines.
October 17, 2003. Health GAP. South African Competition Commission announces stunning victory for access to cheaper drugs, holds GlaxoSmithKline and Boehringer Ingelheim responsible for excessive pricing and other anti-competitive practices.
October 16, 2003. Medecins Sans Frontieres. MSF Welcomes Decision of South African Competition Commission to Promote Access to Medicines.
October 16, 2003. AIDS Healthcare Foundation. AIDS Healthcare Foundation Demands Immediate Action on Voluntary Licensing: South Africa Finds GSK Guilty in Competition Complaint.

News Stories

December 15, 2004. Tamar Kahn for Business Day. Glaxo Grants Cipla Aids-Drug Licence.
July 27, 2004. Tamar Kahn for Business Day. Tribunal to Reopen Glaxo Pricing Case.
June 30, 2004. Tamar Kahn for Business Day. Thembalami Seals Deals On Aids Drugs.
December, 2003. Philippe Rivière for Le Monde Diplomatique. At last, generic anti-AIDS medicine for sub-Saharan Africa.
December 12, 2003. Nicola Mawson And Nawaal Deane for the Mail and Guardian. New Deal Will Open Generic Market for ARVs.
December 11, 2003. Reuters. Glaxo, Boehringer cut a deal on Aids drugs.
December 11, 2003 Michael Wines for the New York Times. Pact to make AIDS drugs cheaper.
December 11, 2003. John Donnelly for the Boston Globe. Deal paves way for generic HIV drugs.
December 11, 2003. Sephanie Nolen for the Globe and Mail. Drug companies make patent concessions.
December 10, 2003. Jodie Ginsburg for Reuters. Glaxo, Boehringer Allow More Copying of AIDS Drugs.
December 10, 2003. South African Press Association. Cheaper Aids drugs on the way.
December 10, 2003. Tamar Kahn for Business Day. Deal Reached On Aids-Drug Prices.
December 10, 2003. BBC. Glaxo responds to Aids drugs call.
December 10, 2003. Voice of America. Glaxo Move Will Bring Cheaper AIDS Drugs to South Africa.
December 10, 2003. The Scottsman. British Company Moves to Cut African Aids Bill.
October 19, 2003. Candace Freeman for BuaNews. Social Development Minister Zola Skweyiya Welcomes Decision by Competition Commission.
Octobeer 17, 2003. Renée Bonorchis for Reuters. Aids drug makers face stiff penalties.
October 17, 2003. Sarah Bosely for the Guardian. Ruling opens the door for cut-price HIV drugs.
October 17, 2003. Editorial in the Guardian. What Glaxo should do is patently obvious.
October 17, 2003. Tamar Kahn for Business Day. Foreign Firms Block Generic Aids Drugs.
October 17, 2003. Lynne Altenroxel for the Independent. Drug firms face stiff fines over pricing.
October 17, 2003. Geoff Dyer for the Financial Times. South Africa revives patent drugs issue.
October 17, 2003. South Africa Business News. GlaxoSmithKline rejects commission findings.
October 17, 2003. Max Gebhardt for the Business Reporter. Glaxo spins local slap into global pat on the back.
October 17, 2003. Mail and Guardian. Drug firm denies abusing position.
October 16, 2003. Nawaal Deane for the Mail and Guardian. SA generic Aids drugs breakthrough. October 2, 2002. Op-ed by Richard Tren for Business Day. AIDS Activists' New Complaint Not Helpful.
Septmeber 20, 2002. Tamar Kahn for Business Day. Drug Companies Come Under Fire.

Return to: CPTech Home -> Main IP Page -> IP and Healthcare-> Main South Africa Page